Kelly CRISPR & Gene Editing Technology ETF

54930008LLNT6JJ4MO84

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Fund
Legal form: 8888
Jurisdiction: United States
Entity created: December 31, 2016

Address

Country: United States
Legal address: CORPORATION TRUST CENTER 1209 ORANGE ST19801 WILMINGTONUnited States (US-DE)
Head office: C/O Kelly CRISPR & Gene Editing Technology ETF, 7887 EAST BELLEVIEW AVE., 1209 ORANGE ST80111 DENVERUnited States (US-CO)

Identifier

LEI: 54930008LLNT6JJ4MO84
Registered: August 25, 2021 at 03:31 PM UTC
Last updated: September 25, 2023 at 02:06 PM UTC
Next renewal: August 24, 2022 at 11:20 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: EDGAR (RA000665)
Identifier: S000073961
Verified against: EDGAR (RA000665)
Verified as: S000073961
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Owned by

Kelly CRISPR & Gene Editing Technology ETF
Fund managerUnited States54930008LLNT6JJ4MO84
STRATEGIC TRUST
Umbrella fundUnited States549300DBTMGXJIJI8N21

Owns1

Kelly CRISPR & Gene Editing Technology ETF
Fund under managementUnited States

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No owner is known to control it

Machine access

REST: https://lei.online/v1/entities/54930008LLNT6JJ4MO84This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search